Geode Capital Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
|
|||||
|
2025
Q1 | $9.24M | Buy |
|
|||||
|
2024
Q4 | $9.91M | Buy |
|
|||||
|
2024
Q3 | $7.25M | Buy |
|
|||||
|
2024
Q2 | $4.48M | Buy |
|
|||||
|
2024
Q1 | $4.57M | Buy |
|
|||||
|
2023
Q4 | $4.78M | Buy |
|
|||||
|
2023
Q3 | $3.27M | Buy |
|
|||||
|
2023
Q2 | $3.43M | Buy |
|
|||||
|
2023
Q1 | $1.75M | Buy |
|
|||||
|
2022
Q4 | $1.42M | Buy |
|
|||||
|
2022
Q3 | $1.9M | Sell |
|
|||||
|
2022
Q2 | $1.42M | Sell |
|
|||||
|
2022
Q1 | $2.72M | Buy |
|
|||||
|
2021
Q4 | $4.4M | Buy |
|
|||||
|
2021
Q3 | $4.56M | Buy |
|
|||||
|
2021
Q2 | $6.06M | Buy |
|
|||||
|
2021
Q1 | $1.64M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $44K | Hold |
|
|||||
|
2019
Q4 | $74K | Hold |
|
|||||
|
2019
Q3 | $135K | Hold |
|
|||||
|
2019
Q2 | $344K | Buy |
|
|||||
|
2019
Q1 | $285K | Hold |
|
|||||
|
2018
Q4 | $304K | Buy |
|
|||||
|
2018
Q3 | $346K | Hold |
|
|||||
|
2018
Q2 | $469K | Buy |
|
|||||
|
2018
Q1 | $533K | Hold |
|
|||||
|
2017
Q4 | $273K | Hold |
|
|||||
|
2017
Q3 | $249K | Hold |
|
|||||
|
2017
Q2 | $270K | Sell |
|
|||||
|
2017
Q1 | $340K | Buy |
|
|||||
|
2016
Q4 | $204K | Buy |
|
|||||
|
2016
Q3 | $310K | Buy |
|
|||||
|
2016
Q2 | $170K | Buy |
|
|||||
|
2016
Q1 | $499 | Sell |
|
|||||
|
2015
Q4 | $684K | Buy |
|
|||||
|
2015
Q3 | $644K | Buy |
|